NeuroSense Therapeutics Granted Key Patent for its ALS Drug PrimeC in Australia – PR Newswire

NeuroSense Therapeutics Granted Key Patent for its ALS Drug PrimeC in Australia – PR Newswire
Source: Google NewsPublished on 2022-03-01